107 related articles for article (PubMed ID: 20684516)
1. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
Barr J; Vázquez-Chantada M; Alonso C; Pérez-Cormenzana M; Mayo R; Galán A; Caballería J; Martín-Duce A; Tran A; Wagner C; Luka Z; Lu SC; Castro A; Le Marchand-Brustel Y; Martínez-Chantar ML; Veyrie N; Clément K; Tordjman J; Gual P; Mato JM
J Proteome Res; 2010 Sep; 9(9):4501-12. PubMed ID: 20684516
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease.
Demirel M; Köktaşoğlu F; Özkan E; Dulun Ağaç H; Gül AZ; Sharifov R; Sarıkaya U; Başaranoğlu M; Selek Ş
Scand J Gastroenterol; 2023; 58(11):1344-1350. PubMed ID: 37337892
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry.
Li JJ; Yang J; Cui WX; Chen XQ; Chen GL; Wen XD; Wang Q
Evid Based Complement Alternat Med; 2013; 2013():451975. PubMed ID: 24066013
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD.
Fotakis C; Kalafati IP; Amanatidou AI; Andreou V; Matzapetakis M; Kafyra M; Varlamis I; Zervou M; Dedoussis GV
Front Endocrinol (Lausanne); 2023; 14():1230457. PubMed ID: 37854184
[TBL] [Abstract][Full Text] [Related]
5. The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease.
Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF
Pathology; 2024 Apr; 56(3):391-397. PubMed ID: 38071157
[TBL] [Abstract][Full Text] [Related]
6. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease.
Sen P; Govaere O; Sinioja T; McGlinchey A; Geng D; Ratziu V; Bugianesi E; Schattenberg JM; Vidal-Puig A; Allison M; Cockell S; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
iScience; 2022 Sep; 25(9):104949. PubMed ID: 36065182
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD).
Li X; Xiao Y; Chen X; Zhu Y; Du H; Shu J; Yu H; Ren X; Zhang F; Dang J; Zhang C; Su S; Li Z
J Proteome Res; 2024 May; ():. PubMed ID: 38698681
[TBL] [Abstract][Full Text] [Related]
8. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.
Barr J; Caballería J; Martínez-Arranz I; Domínguez-Díez A; Alonso C; Muntané J; Pérez-Cormenzana M; García-Monzón C; Mayo R; Martín-Duce A; Romero-Gómez M; Lo Iacono O; Tordjman J; Andrade RJ; Pérez-Carreras M; Le Marchand-Brustel Y; Tran A; Fernández-Escalante C; Arévalo E; García-Unzueta M; Clement K; Crespo J; Gual P; Gómez-Fleitas M; Martínez-Chantar ML; Castro A; Lu SC; Vázquez-Chantada M; Mato JM
J Proteome Res; 2012 Apr; 11(4):2521-32. PubMed ID: 22364559
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
[TBL] [Abstract][Full Text] [Related]
10. Deciphering non-alcoholic fatty liver disease through metabolomics.
Cano A; Alonso C
Biochem Soc Trans; 2014 Oct; 42(5):1447-52. PubMed ID: 25233430
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.
Gorden DL; Myers DS; Ivanova PT; Fahy E; Maurya MR; Gupta S; Min J; Spann NJ; McDonald JG; Kelly SL; Duan J; Sullards MC; Leiker TJ; Barkley RM; Quehenberger O; Armando AM; Milne SB; Mathews TP; Armstrong MD; Li C; Melvin WV; Clements RH; Washington MK; Mendonsa AM; Witztum JL; Guan Z; Glass CK; Murphy RC; Dennis EA; Merrill AH; Russell DW; Subramaniam S; Brown HA
J Lipid Res; 2015 Mar; 56(3):722-736. PubMed ID: 25598080
[TBL] [Abstract][Full Text] [Related]
12. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
[TBL] [Abstract][Full Text] [Related]
13. Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.
Gonzalez E; van Liempd S; Conde-Vancells J; Gutierrez-de Juan V; Perez-Cormenzana M; Mayo R; Berisa A; Alonso C; Marquez CA; Barr J; Lu SC; Mato JM; Falcon-Perez JM
Metabolomics; 2012; 8(6):997-1011. PubMed ID: 23139648
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.
Mayo R; Crespo J; Martínez-Arranz I; Banales JM; Arias M; Mincholé I; Aller de la Fuente R; Jimenez-Agüero R; Alonso C; de Luis DA; Vitek L; Stritesky J; Caballería J; Romero-Gómez M; Martín-Duce A; Mugüerza Huguet JM; Busteros-Moraza JI; Idowu MO; Castro A; Martínez-Chantar ML; Ortiz P; Bruha R; Lu SC; Bedossa P; Noureddin M; Sanyal AJ; Mato JM
Hepatol Commun; 2018 Jul; 2(7):807-820. PubMed ID: 30027139
[TBL] [Abstract][Full Text] [Related]
15. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.
Loomba R; Quehenberger O; Armando A; Dennis EA
J Lipid Res; 2015 Jan; 56(1):185-92. PubMed ID: 25404585
[TBL] [Abstract][Full Text] [Related]
17. Lipidomics profiles of human spermatozoa: insights into capacitation and acrosome reaction using UPLC-MS-based approach.
Cheng X; Xie H; Xiong Y; Sun P; Xue Y; Li K
Front Endocrinol (Lausanne); 2023; 14():1273878. PubMed ID: 38027124
[TBL] [Abstract][Full Text] [Related]
18. Dietary ω3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study.
Padro T; López-Yerena A; Pérez A; Vilahur G; Badimon L
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630826
[TBL] [Abstract][Full Text] [Related]
19. High Fat Diet Mediated Alterations in Serum Sphingolipid Profiles in An Experimental Mouse Model Measured by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry.
Yalcin EB; Tong M; Cao K; Huang CK; de la Monte S
Eur J Biol Biotechnol; 2023 Feb; 4(1):25-32. PubMed ID: 36994093
[TBL] [Abstract][Full Text] [Related]
20. Elevation of Lipid Metabolites in Deceased Liver Donors Reflects Graft Suffering.
Lee WC; Wu TJ; Cheng CH; Wang YC; Hung HC; Lee JC; Wu TH; Chou HS; Lee CF; Chan KM
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
